These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 12097192)

  • 1. Serotonin antagonist profiling on 5HT2A and 5HT2C receptors by nonequilibrium intracellular calcium response using an automated flow-through fluorescence analysis system, HT-PS 100.
    Kaler G; Otto M; Okun A; Okun I
    J Biomol Screen; 2002 Jun; 7(3):291-301. PubMed ID: 12097192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems.
    Watson J; Collin L; Ho M; Riley G; Scott C; Selkirk JV; Price GW
    Br J Pharmacol; 2000 Jul; 130(5):1108-14. PubMed ID: 10882396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human trabecular meshwork cells express functional serotonin-2A (5HT2A) receptors: role in IOP reduction.
    Sharif NA; Kelly CR; McLaughlin M
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4001-10. PubMed ID: 16936116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport.
    Mayer SE; Sanders-Bush E
    Mol Pharmacol; 1994 May; 45(5):991-6. PubMed ID: 8190114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
    Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.
    Newman-Tancredi A; Cussac D; Quentric Y; Touzard M; Verrièle L; Carpentier N; Millan MJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):815-22. PubMed ID: 12388668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evidence that 5-hydroxytryptamine increases efflux of glial glutamate via 5-HT(2A) receptor activation.
    Meller R; Harrison PJ; Elliott JM; Sharp T
    J Neurosci Res; 2002 Feb; 67(3):399-405. PubMed ID: 11813245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
    Sheldon PW; Aghajanian GK
    Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors.
    Acuña-Castillo C; Villalobos C; Moya PR; Sáez P; Cassels BK; Huidobro-Toro JP
    Br J Pharmacol; 2002 Jun; 136(4):510-9. PubMed ID: 12055129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays.
    Rogines-Velo MP; Pelorosso FG; Zold CL; Nowak W; Pesce GO; Sardi SP; Brodsky PT; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):587-95. PubMed ID: 12444501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and functional expression of cloned rat serotonin 5HT-2 receptor.
    Pritchett DB; Bach AW; Wozny M; Taleb O; Dal Toso R; Shih JC; Seeburg PH
    EMBO J; 1988 Dec; 7(13):4135-40. PubMed ID: 2854054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bioluminescent aequorin for the pharmacological characterization of 5HT receptors.
    Schaeffer MT; Cully D; Chou M; Liu J; Van der Ploeg LH; Fong TM
    J Recept Signal Transduct Res; 1999 Nov; 19(6):927-38. PubMed ID: 10533981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes.
    Shenker A; Maayani S; Weinstein H; Green JP
    Mol Pharmacol; 1987 Apr; 31(4):357-67. PubMed ID: 2952874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
    Calama E; Fernández MM; Morán A; Martín ML; San Román L
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats.
    Morán A; de Urbina AV; Martín ML; Rodríguez-Barbero A; Román LS
    Eur J Pharmacol; 2009 Oct; 620(1-3):90-6. PubMed ID: 19699736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 2. Evidence of involvement of 5-HT1B receptors using functional studies.
    Rogines-Velo MP; Pelorosso FG; Zold CL; Brodsky PT; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):596-604. PubMed ID: 12444502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.